Literature DB >> 702321

A study of the effect of delta 9-tetrahydrocannabinol (delta 9-THC) on mammalian salivary flow.

W R McConnell, W L Dewey, L S Harris, J F Borzelleca.   

Abstract

delta 9-Tetrahydrocannabinol (delta 9-THC) caused no change in either pilocarpine or acetylcholine (ACh)-stimulated salivary flow of the cat but significantly decreased salivary flow from the submaxillary gland of the car and dog during electrical stimulation of the chorda tympani. In contributing to this effect, delta 9-THC significantly decreased (47%) basal arterial blood flow to the submaxillary gland of the dog and markedly reduced (51%) the stimulated blood flow to the gland produced by electrical stimulation of the chorda tympani. The decrease in stimulated blood flow by delta 9-THC suggested an effect on the ACh of the gland. No decrease in the synthesis of ACh could be demonstrated in the submaxillary gland of the dog. A significant decrease (37%) in the release of ACh from transmurally stimulated guinea-pig ileum, a model tissue, was produced by delta 9-THC. These data suggest that delta 9-THC decreases electrically stimulated salivary flow by a mechanism involving the decrease in release of ACh which results in a reduction of blood flow to the submaxillary gland, and, also, less ACh for stimulation of the secretory cells of the gland.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702321

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.

Authors:  A H Lichtman; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 2.  A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.

Authors:  Salahaden R Sultan; Sophie A Millar; Saoirse E O'Sullivan; Timothy J England
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-31

3.  Cannabis Extract CT-921 Has a High Efficacy-Adverse Effect Profile in a Neuropathic Pain Model.

Authors:  Elham Rouhollahi; Bernard A MacLeod; Alasdair M Barr; Ernest Puil
Journal:  Drug Des Devel Ther       Date:  2020-08-17       Impact factor: 4.162

4.  Cannabinoid CB1 receptors regulate salivation.

Authors:  Kelsey Andreis; Jenna Billingsley; Kian Naimi Shirazi; Jim Wager-Miller; Clare Johnson; Heather Bradshaw; Alex Straiker
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

5.  THC Regulates Tearing via Cannabinoid CB1 Receptors.

Authors:  Amanda Thayer; Natalia Murataeva; Vanessa Delcroix; Jim Wager-Miller; Helen P Makarenkova; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.